SPOC PROTEOMICS INC.
Medtech · Private
Benchtop instrument (Genetein) for semi-automated in situ protein array production using DNA arrays to express and capture proteins on slides for biomarker discovery and assays
spoc.bio →- Grants
- $7.3M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery | $871,162 | |
| Federal grant | Department of Health and Human Services · Phase I · Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery | $349,552 | |
| Federal grant | Department of Health and Human Services · Phase I · Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery | $172,040 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery | $324,180 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery | $974,700 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Sensor Integrated Proteome on Chip (SPOC) platform for evaluating kinetic parameters of protein interactions in high throughput | $1,178,727 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery | $1,024,700 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel Sensor Integrated Proteome on Chip (SPOC) platform for evaluating kinetic parameters of protein interactions in high throughput | $1,070,227 | |
| Federal grant | Department of Health and Human Services · Phase II · Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery | $1,370,834 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2190 | CIRCADIAN MANAGEMENT, INC. | — | — |
| 2191 | LIVIVOS INC. | — | — |
| 2192 | KINETICA LABS, INC. | — | — |
| 2193 | SPOC PROTEOMICS INC. | — | — |
| 2194 | GLYCOMIRA, LLC | — | — |
| 2195 | Mozaic Medical Inc | — | $225K |
| 2196 | Aikili Biosystems Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Real-time surface plasmon resonance versus traditional endpoint techniques: Implications for diagnostics and off-target toxicity screeningapplication
- Methods And Systems For Detecting One Or More Analytes Associated With One Or More Autoimmune Diseasesapplication
- Immunoglobulin-like Proteins Arrayed On Biosensors And Plasma Proteomicsapplication
- Immunoglobulin-like And Mutationally Scanned Proteins Arrayed On Biosensors For Drug Discovery And Developmentapplication
- Sensor-integrated proteome on chip (SPOC) for drug discovery and diagnosticsapplication
- Multiplexed Biosensor Arrays For Biopharmaceutical Characterization Assays, Companion Diagnostics, And Other Related Usesapplication
- Methods And Systems For Detecting One Or More Autoantibodies And/or Analytes Associated With One Or More Autoimmune Diseasesapplication
- Methods And Systems For Detecting One Or More Analytes Associated With One Or More Autoimmune Diseasesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.